The Global Bioanalytical Testing Services Market is witnessing strong expansion driven by increasing pharmaceutical R and D, rising clinical trial activity, and growing demand for biologics and biosimilars. According to industry insights, the market continues to evolve as outsourcing analytical testing becomes a strategic priority for life sciences companies. The is playing a crucial role in...

Growing investment in personalized medicine is fueling the need for high-quality plasmid DNA. Biopharmaceutical companies are expanding manufacturing capabilities to support clinical and commercial supply. The market is becoming a critical foundation for next-generation therapeutic development. DNA Plasmid Manufacturing Market to Hit US$ 2.65B by 2031 Boom The DNA plasmid manufacturing market...

Global fungal enzyme market size was valued at USD 2.4 billion in 2024. The market is projected to grow from USD 2.6 billion in 2025 to USD 4.3 billion by 2032, exhibiting a CAGR of 7.5% during the forecast period. Fungal enzymes serve as biocatalysts with unparalleled specificity, enabling breakthroughs in waste valorization and precision fermentation. Their eco-friendly profile has gained...

According to a new report from Intel Market Research, the global Herpes Simplex Virus (HSV) Vaccines market was valued at USD 865 million in 2024 and is projected to reach USD 1,360 million by 2034, growing at a robust CAGR of 6.8% during the forecast period (2025–2034). This growth is driven by the increasing global prevalence of HSV infections, rising awareness about sexually...

As biologically inspired nanocarriers, virus-like particles combine safety with functional adaptability. Their capacity for modular design supports innovation in immunotherapy, targeted drug delivery, and advanced diagnostic technologies. The global virus-like particles market is entering a phase of sustained expansion, with projected growth from US$ 6.25 billion in 2025 to US$ 12.15 billion by...

As biologically inspired nanocarriers, virus-like particles combine safety with functional adaptability. Their capacity for modular design supports innovation in immunotherapy, targeted drug delivery, and advanced diagnostic technologies. The global virus-like particles market is entering a phase of sustained expansion, with projected growth from US$ 6.25 billion in 2025 to US$ 12.15 billion by...